SEC Filing Madrigal Pharmaceuticals.

SEC Filing Madrigal Pharmaceuticals.

SEC Filing NeuroBo Pharmaceuticals, Inc.

DEF 14A

Madrigal Pharmaceuticals: Odds Shortening On NASH Drug Approval (NASDAQ:MDGL)

g716223.jpg

Conshohocken-based Madrigal Pharmceuticals plans a $500M stock sale - Philadelphia Business Journal

SEC Filing Deciphera Pharmaceuticals, Inc.

Madrigal Pharmaceuticals Inc - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of

Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why

SEC Filing NeuroBo Pharmaceuticals, Inc.

SEC Filing Madrigal Pharmaceuticals.

Madrigal Pharmaceuticals (NASDAQ:MDGL) Lowered to Sell at B. Riley - Defense World

Madrigal Pharmaceuticals Announces EMA Validation of its Marketing Authorization Application for Resmetirom for the Treatment of NASH/MASH with Liver Fibrosis

Madrigal Pharmaceuticals Inc Trademarks & Logos